Meta‐analysis of the correlation between TP53 mutation with progress in advanced bladder cancer resulted in p < 0.00001 and I2 = 0%, presenting that there was no heterogeneity, and the sensitivity analysis and the subgroup analysis did not be carried out. The gene discussed is TP53; the disease is urinary bladder carcinoma.